Post-prandial plasma glucose

2 papers study it4 more mention it1 finding

Human trial2

Interventions

1

Acarbose

downin humans1

1 study

Acarbose decreases post-prandial plasma glucose in humans.
“Post-prandial plasma glucose decrease was observed in acarbose group compared to the baseline value and to the end of titration period.”
Human trialin type 2 diabetic patients treated with sulphonylureas and metformin
Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin
Journal of clinical pharmacy and therapeuticsOct 1, 2010

More on Acarbose

Latest

Journal of Clinical Pharmacy and TherapeuticsOct 1

Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin

Randomized trial in 473 peoplePioglitazone

Clinical Drug InvestigationJan 1

Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance

Randomized trial in 107 peopleImpaired glucose tolerance

Saudi Medical JournalFeb 14

The effects of celery leaf (apium graveolens L.) treatment on blood glucose and insulin levels in elderly pre-diabetics

Trial in peopleInterventions

Endocrine JournalJul 30

Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients

Randomized trial in 258 peopleInterventions

Diabetes & MetabolismJun 1

Acarbose improves indirectly both insulin resistance and secretion in obese type 2 diabetic patients

Randomized trial in 17 peopleInterventions

Clinical and Investigative Medicine Medecine Clinique et ExperimentaleAug 1

Clinical experience with acarbose: results of a Canadian multicentre study

Randomized trial in peopleInterventions